Name | 1-cyclopropyl-6-fluoro-7-[(8E)-8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid |
---|---|
Synonyms |
Zabofloxacin
1,8-Naphthyridine-3-carboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[(8Z)-8-(methoxyimino)-2,6-diazaspiro[3.4]oct-6-yl]-4-oxo- UNII-LV66BA6V2G 1-Cyclopropyl-6-fluoro-7-[(8Z)-8-(methoxyimino)-2,6-diazaspiro[3.4]oct-6-yl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
Description | Zabofloxacin (DW-224a Free base) is a novel fluoronaphthyridone quinolone with a 7-pyrrolidone substituent that is considered a potent antibacterial candidate for clinical trials.Zabofloxacin (DW-224a Free base) has excellent activity against gram-positive pathogens including Steptococcus aureus , Streptococcus pyogenes and S.pneumonia.Zabofloxacin (DW-224a Free base) is considered as an alternative candidate for treatment of quinolone-susceptible (QSSP) and quinolone-resistant gonorrhea (QRSP)[1]. |
---|---|
Related Catalog | |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 658.7±65.0 °C at 760 mmHg |
Molecular Formula | C19H20FN5O4 |
Molecular Weight | 401.392 |
Flash Point | 352.2±34.3 °C |
Exact Mass | 401.149933 |
PSA | 109.05000 |
LogP | 1.11 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.771 |
Storage condition | -20°C |